Ignite Creation Date:
2024-05-06 @ 3:54 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04790474
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-04-21
First Post:
2021-03-07
Brief Title:
Ixazomib-pomalidomide-dexamethasone As Second or Third-line Combination Treatment for Patients with Relapsed and Refractory Multiple Myeloma Previously Treated with Daratumumab Lenalidomide and Bortezomib
Sponsor:
Tel-Aviv Sourasky Medical Center
Organization:
Tel-Aviv Sourasky Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-07
First Submit QC Date:
March 9 2021
Study First Post Date:
2021-03-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-16
Last Update Post Date:
2023-04-21
Last Update Post Date Type:
ACTUAL